John T. Henderson - Dec 18, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Henderson
Stock symbol
CYTK
Transactions as of
Dec 18, 2023
Transactions value $
-$1,829
Form type
4
Date filed
12/19/2023, 04:12 PM
Previous filing
Oct 3, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $87.5K +13K +40.92% $6.72* 44.8K Dec 18, 2023 Direct F1, F2
transaction CYTK Common Stock Sale -$89.3K -2.46K -5.48% $36.34 42.4K Dec 18, 2023 Direct F1, F2
holding CYTK Common Stock 83 Dec 18, 2023 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -13K -100% $0.00* 0 Dec 18, 2023 Common Stock 13K $6.72 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.
F2 Sell-to-cover transaction. Dr. Henderson acquired a net 10,562 shares of common stock, which he continues to hold.